Skip to main content
. Author manuscript; available in PMC: 2023 Mar 4.
Published in final edited form as: Biomed Mater. 2022 Mar 4;17(2):10.1088/1748-605X/ac5574. doi: 10.1088/1748-605X/ac5574

Table 1.

Animal models deficient in adaptive immunity and FBR

Animal Model Polymer Implantation Model Duration Compared to WT? Measured Outcomes Reference

hypogammaglobulinemic
CB-17 SCID mice
PET intraperitoneal 16 hours Y No change (leukocyte accumulation) [86]
B cells & T cells (deficient)
CB-17 SCID mice
PGA-P(CL/LA) & PLLA-P(CL/LA) inferior vena cava & aorta 21–42 days N No change (leukocyte accumulation, FBGC formation, collagen deposition, vascularization) [84]
T cells (deficient)
BALB/C nude mice
PEU & PET & SR subcutaneous (cage implant) 7–21 days Y No change (leukocyte accumulation*, FBGC formation)
*Lower adherent cell densities in nude mice with PET at day 7 &
PEU at day 21.
[80]
T cells (deficient)
BALB/C nude mice
PCL-Gelatin-HA subcutaneous 28–56 days N No change (fibrous encapsulation) [82]
NK cells (deficient)
C57BL/6J mice
NKT cells (deficient)
BALB/CJ mice
IL-4Ra (deficient)
BALB/CJ mice
PEU & PET subcutaneous 14–28 days Y No change (leukocyte accumulation, FBGC formation) [83]
mast cells (deficient)
C57BL/6J mice
B cells & T cells (deficient)
C57BL/6J SCID mice
T cells (deficient)
BALB/C nude mice
PCL-CaP subcutaneous 4–14 days Y No change (collagen deposition), vascularization ↑ [81]
IFN-γ (KO)
C57BL/6 mice
PE-PUR subcutaneous 7 days Y leukocyte accumulation ↓, vascularization ↓, pro-inflammatory cytokines ↓, anti-inflammatory cytokine ↑, collagen deposition ↓ [97]
MyD88 (KO)
B6.129P2(SJL)-
MyD 8 8 <tm 1.1Defr>/J mice
PEG subcutaneous 2–28 days Y leukocyte accumulation ↓, fibrous encapsulation ↓, vascularization ↓ [96]
T cells (deficient)
C57BL/6 nude mice
PDMS subcutaneous 21 –42 days Y 0 |am, Ra: No change (leukocyte accumulation & fibrous encapsulation) 40 ^m, Ra: leukocyte accumulation ↑ & fibrous encapsulation ↑ [141]
IL-17A (KO) & IL-17RA (KO)
C57BL/6J mice
PCL intramuscular 42–84 days Y leukocyte accumulation ↓, fibrosis-related gene expression ↓, collagen deposition ↓, fibrous encapsulation ↓, fiber diameter ↓ [10]
B cells (KO)
C57BL/6J muMt-mice
PCL intramuscular 7–42 days Y No change (leukocyte accumulation), fibrosis-related gene expression ↓, collagen deposition ↓ [79]
B cells & T cells (deficient)
CB-17 NOD SCID mice
PVA subcutaneous 2–14 days Y No change (leukocyte accumulation) [85]
T cells (deficient)
CBH-rnu/Arc nude rats
PA-Gelatin subcutaneous 7–90 days N No change (leukocyte accumulation, vascularization, collagen deposition, fibrotic tissue ingrowth) [110],
[111]
T cells (deficient)
Sprague-Dawley nude rats
PPF-pericardium subcutaneous 42 days Y No change (leukocyte accumulation) [17]